Protease-activated receptor 2 sensitizes TRPV1 by protein kinase Cepsilon- and A-dependent mechanisms in rats and mice.
about
Brachystemma calycinum D. Don Effectively Reduces the Locomotor Disability in Dogs with Naturally Occurring Osteoarthritis: A Randomized Placebo-Controlled TrialModerate ethanol ingestion and cardiovascular protection: from epidemiologic associations to cellular mechanismsProteinase-activated receptor-2 mediated inhibition of TNFalpha-stimulated JNK activation - A novel paradigm for G(q/11) linked GPCRsTRP channels in neurogastroenterology: opportunities for therapeutic interventionThe substrates and binding partners of protein kinase CepsilonThe emergence of proteinase-activated receptor-2 as a novel target for the treatment of inflammation-related CNS disordersThe role of Transient Receptor Potential Vanilloid 1 (TRPV1) channels in pancreatitisTreatment of Cancer Pain by Targeting CytokinesBiologic mechanisms of oral cancer pain and implications for clinical therapyNanotechnology-based drug delivery systems for treatment of oral cancer: a reviewNew insights into the mechanisms of itch: are pain and itch controlled by distinct mechanisms?Development and evaluation of small peptidomimetic ligands to protease-activated receptor-2 (PAR2) through the use of lipid tetheringHypersensitivity Induced by Activation of Spinal Cord PAR2 Receptors Is Partially Mediated by TRPV1 ReceptorsProteinase-activated receptor-4 (PAR4) activation leads to sensitization of rat joint primary afferents via a bradykinin B2 receptor-dependent mechanismThe multiple pathways for itch and their interactions with painPost-synaptic density perturbs insulin-induced Kv1.3 channel modulation via a clustering mechanism involving the SH3 domain.Protease-activated receptor 2-mediated protection of myocardial ischemia-reperfusion injury: role of transient receptor potential vanilloid receptors.Transient receptor potential ankyrin-1 has a major role in mediating visceral pain in mice.Identifying the Ion Channels Responsible for Signaling Gastro-Intestinal Based PainSerine proteases and protease-activated receptor 2-dependent allodynia: a novel cancer pain pathway.[EXPRESS] Ion channels and neuronal hyperexcitability in chemotherapy-induced peripheral neuropathy; cause and effect?Mechanism of cancer pain.Serine proteases and protease-activated receptor 2 mediate the proinflammatory and algesic actions of diverse stimulants.Mast cells: versatile gatekeepers of pain.PKCε phosphorylation of the sodium channel NaV1.8 increases channel function and produces mechanical hyperalgesia in mice.The active Zot domain (aa 288-293) increases ZO-1 and myosin 1C serine/threonine phosphorylation, alters interaction between ZO-1 and its binding partners, and induces tight junction disassembly through proteinase activated receptor 2 activationTRPV1 activation is required for hypertonicity-stimulated inflammatory cytokine release in human corneal epithelial cells.The protease-activated receptor-2-specific agonists 2-aminothiazol-4-yl-LIGRL-NH2 and 6-aminonicotinyl-LIGRL-NH2 stimulate multiple signaling pathways to induce physiological responses in vitro and in vivoTRPV4-mediated calcium influx into human bronchial epithelia upon exposure to diesel exhaust particles.The distinct roles of two GPCRs, MrgprC11 and PAR2, in itch and hyperalgesia.Nociceptor beta II, delta, and epsilon isoforms of PKC differentially mediate paclitaxel-induced spontaneous and evoked pain.Whiplash-like facet joint loading initiates glutamatergic responses in the DRG and spinal cord associated with behavioral hypersensitivity.Protease-activated receptor 2 activation is sufficient to induce the transition to a chronic pain stateNew insights into protease-activated receptor 4 signaling pathways in the pathogenesis of inflammation and neuropathic pain: a literature reviewProtease-activated receptors (PARs)--biology and role in cancer invasion and metastasis.P2Y1 Receptor Activation of the TRPV4 Ion Channel Enhances Purinergic Signaling in Satellite Glial Cells.Protease-activated receptor 2 (PAR2) protein and transient receptor potential vanilloid 4 (TRPV4) protein coupling is required for sustained inflammatory signaling.Inflammatory mediators modulating the transient receptor potential vanilloid 1 receptor: therapeutic targets to treat inflammatory and neuropathic pain.Potentiation of the transient receptor potential vanilloid 1 channel contributes to pruritogenesis in a rat model of liver disease.Evidence for the role of neurogenic inflammation components in trypsin-elicited scratching behaviour in mice.
P2860
Q21285007-0E88C581-E32E-43B1-802C-C9EA3A56D816Q22251417-D8DD7273-18FD-4343-A9CE-1B78365F0FF3Q24318701-F7070937-75A2-420A-91D9-5CD1060A4FBDQ24618774-6F04DBAA-88A6-4A47-BF56-29AD37730EFFQ24620820-7986B578-6562-4F41-9E3D-393E41DA783EQ24679499-6A6DFAB4-B47E-4A78-8EDA-F39973D9DF2AQ24679996-93809022-1A3D-4B66-B0FF-27420C66ACCDQ26779917-695FC229-9A01-4413-B544-3AE6A8C5D3DAQ26865216-BA608815-894C-4629-A91C-92C18643507FQ26995835-F5D5C035-9AFE-4116-83F5-2CA2A639BF40Q27692549-794AF9BB-B823-4DC7-8DE6-F794516ABA00Q28539692-3862CCD3-D733-45C8-85D4-11D872321A56Q28552751-CAD720BD-9F60-4AAF-8B39-886B36CAC10BQ28568009-DA87E7E0-AA54-4D9B-BF94-C94EAE2F4A0CQ29306039-158E751D-C99A-4FA9-8822-184C9B0693C8Q30157768-DA4CC0E0-493F-47AE-B8D1-ABC6B8270173Q33579239-08FA744D-8621-41AC-97B9-27EF62F4A1DFQ33588995-F4D7967B-5FB5-4D79-9B5A-F9006BEB5069Q33664676-D1184038-8A88-4EE7-BB78-2F1A40078258Q33818974-5CB8743E-60A4-4F08-80D0-9C47146978E7Q33824948-D5D3D5D2-55D0-4127-A653-AEC54C1BE431Q33953901-8E788E91-EA23-4B60-8C5C-6B01B29D251BQ34025076-FC95C11B-2F27-4FB6-A312-8B53A1D0B5E1Q34225889-9AE3BB2D-C5E9-4F09-AE7C-027425BBFC88Q34262020-F5C47675-D979-47A0-AE23-BC8538FFA241Q34421772-3BE87F1B-293B-40CD-BBA8-01560792D89CQ34646774-BD1D8C18-2811-45D1-B685-65B2EA9CD2F6Q34998283-A223177F-B33A-4D97-8DD2-15972009DB47Q35044737-DA74CDE6-1B29-442D-88B5-475EFD4B9A8BQ35130579-75659A0A-CFFE-4A93-A30A-E813AE081FA0Q35187458-7FB3FA2D-E4B9-448D-AFEB-B07BE7C64C24Q36010787-5ECE60D9-B382-4348-B913-05DF06D928C1Q36108394-19CD099E-A3B3-4CCA-993C-A58645A9A8F3Q36125100-FAA86C22-4C81-4781-9E00-81664AD9DB8FQ36322931-E5A0A17C-1264-430A-A879-DB3CB050120DQ36323532-04D9C22F-F8EC-4451-B168-8628B61FF05BQ36635888-DC7A0198-AF48-423A-9E1A-8000C60AF9C5Q36734927-99BD5752-0AC7-46DE-9556-DA7CB9B55F1FQ36742184-546F5E44-9B4C-42F9-8151-ACC70B4B06A7Q36753567-660C59A4-97FC-4CA7-8377-215D2F2A2362
P2860
Protease-activated receptor 2 sensitizes TRPV1 by protein kinase Cepsilon- and A-dependent mechanisms in rats and mice.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Protease-activated receptor 2 ...... t mechanisms in rats and mice.
@en
type
label
Protease-activated receptor 2 ...... t mechanisms in rats and mice.
@en
prefLabel
Protease-activated receptor 2 ...... t mechanisms in rats and mice.
@en
P2093
P2860
P1476
Protease-activated receptor 2 ...... t mechanisms in rats and mice.
@en
P2093
Carlos Barajas-Lopez
Eileen F Grady
Francisco Bautista
Graeme S Cottrell
Kevin Chapman
Lorna Divino
Nigel W Bunnett
Rustum Karanjia
Silvia Amadesi
Stephen Vanner
P2860
P304
P356
10.1113/JPHYSIOL.2006.111534
P407
P577
2006-06-22T00:00:00Z